(Q40132843)

English

Cytotoxic polyketides containing tetramic acid moieties isolated from the fungus Myceliophthora Thermophila: elucidation of the relationship between cytotoxicity and stereoconfiguration

scientific article published on January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Cytotoxic polyketides containing tetramic acid moieties isolated from the fungus Myceliophthora Thermophila: elucidation of the relationship between cytotoxicity and stereoconfiguration (English)

1 reference

Europe PubMed Central

17 September 2017

Myceliophthora thermophila

1 reference

Thermothelomyces thermophilus

1 reference

3-[(1R,2S,4aS,6S,8aR)-2-but-2-en-2-yl-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-5-(2-methylpropylidene)pyrrol-2-one

1 reference

(5R)-3-[(1R,2S,4aS,6S,8aR)-2-but-2-en-2-yl-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)-1H-pyrrol-2-one

1 reference

(5S)-3-[(1R,2S,4aS,6S,8aR)-2-but-2-en-2-yl-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-5-hydroxy-5-(2-methylpropyl)-1H-pyrrol-2-one

1 reference

Myceliothermophin B

1 reference

(5S)-3-[(1R,2S,4aS,6S,8aR)-2-but-2-en-2-yl-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)-1H-pyrrol-2-one

1 reference

Myceliothermophin E

1 reference

3-[2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-5-methoxy-5-(2-methylpropyl)pyrrol-2-ol

1 reference

Myceliothermophin D

1 reference

Myceliothermophin C

1 reference

(5R)-3-[(1R,2S,4aS,6S,8aR)-2-but-2-en-2-yl-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-5-hydroxy-5-(2-methylpropyl)-1H-pyrrol-2-one

1 reference

Myceliothermophin A

1 reference

4-[2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-2-(2-methylpropyl)pyrrole-2,5-diol

1 reference

3-[2-(but-2-en-2-yl)-3,4a,6-trimethyl-2,5,6,7,8,8a-hexahydro-1H-naphthalene-1-carbonyl]-5-(2-methylpropylidene)pyrrol-2-ol

1 reference

author name string

Yu-Liang Yang

1

1 reference

Europe PubMed Central

17 September 2017

Chun-Ping Lu

2

1 reference

Europe PubMed Central

17 September 2017

Mao-Yen Chen

3

1 reference

Europe PubMed Central

17 September 2017

Kuei-Yu Chen

4

1 reference

Europe PubMed Central

17 September 2017

Yang-Chang Wu

5

1 reference

Europe PubMed Central

17 September 2017

Shih-Hsiung Wu

6

1 reference

Europe PubMed Central

17 September 2017

language of work or name

0 references

publication date

17 August 2007

1 reference

16 September 2022

full work available at URL

http://ntur.lib.ntu.edu.tw/news/agent_contract.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1002/chem.200700038?email=unpaywall_01@example.com

Chemistry—A European Journal

1 reference

Europe PubMed Central

17 September 2017

13

1 reference

Europe PubMed Central

17 September 2017

24

1 reference

Europe PubMed Central

17 September 2017

6985-6991

1 reference

Europe PubMed Central

17 September 2017

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1002/chem.200700038?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Fusarin C biosynthesis in Fusarium moniliforme and Fusarium venenatum.

2 references

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/CBIC.200400138

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third-generation dolastatin-15 analogue, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors.

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

UCS1025A, a novel antibiotic produced by Acremonium sp

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Antifungal substances against pathogenic fungi, talaroconvolutins, from talaromyces convolutus

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Protein-reactive natural products

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Oteromycin: A Novel Antagonist of Endothelin Receptor

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Ascosalipyrrolidinone A, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Biosynthetic studies of the tetramic acid antibiotic trichosetin

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

ZG-1494 alpha, a novel platelet-activating factor acetyltransferase inhibitor from Penicillium rubrum, isolation, structure elucidation andbiological activity

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Isolation and structure of the cytostatic linear depsipeptide dolastatin 15

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

UCS1025A and B, new antitumor antibiotics from the fungus Acremonium species

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Determination by asymmetric total synthesis of the absolute configuration of lucilactaene, a cell-cycle inhibitor in p53-transfected cancer cells

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors

1 reference

9 March 2024

https://opencitations.net/index/api/v1/references/10.1002/CHEM.200700038

Identifiers

10.1002/CHEM.200700038

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40132843&oldid=2106506540"